developing countries
Showing 26 - 50 of >10,000
Collision of Three Global Pandemics: Effect of Tuberculosis and
Not yet recruiting
- COVID-19
- +3 more
- Covid-19, TB and HIV diagnosis
- (no location specified)
Mar 2, 2022
Post-kala-azar Dermal Leishmaniasis Trial (Vaccine, Placebo)
Not yet recruiting
- Post-kala-azar Dermal Leishmaniasis
- Vaccine
- Placebo
- (no location specified)
Jan 20, 2022
Covid19, Morbidity, Absenteeism Trial in Bissau, Manhiça (BCG-Denmark, Saline)
Completed
- Covid19
- +2 more
- BCG-Denmark
- Saline
-
Bissau, SAB, Guinea-Bissau
- +1 more
Nov 2, 2022
Severe Malaria Trial in Worldwide (KAE609, IV Artesunate, Coartem)
Recruiting
- Severe Malaria
- KAE609
- +2 more
-
Kinsasha, Democratic Republic Of Congo, Congo
- +6 more
Sep 23, 2022
Group B Streptococcal Infection Trial in Johannesburg, Kawempe (GBS-NN/NN2, Placebo)
Active, not recruiting
- Group B Streptococcal Infection
- GBS-NN/NN2
- Placebo
-
Johannesburg, South Africa
- +2 more
Aug 29, 2022
Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis Trial in Cape Town (BTZ-043, Rifafour e-275®, Probe Drug
Completed
- Pulmonary Tuberculoses
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +1 more
Aug 9, 2022
Helminthes; Infestation, Intestinal Trial in Nairobi (Albendazole and Ivermectin fixed dose coformulation, Albendazole)
Recruiting
- Helminthes; Infestation, Intestinal
- Albendazole and Ivermectin fixed dose coformulation
- Albendazole
-
Bahir Dar, Ethiopia
- +2 more
Dec 16, 2022
Adoption of L-PZQ for Schistosomiasis by Endemic Counties -
Recruiting
- Schistosomiasis in Children
- Social Acceptance
- Community pilot L-PZQ distribution - intervention is NOT part of this observational study
-
Abidjan, Côte D'Ivoire
- +2 more
Apr 21, 2022
Tuberculosis, HIV-1-infection, Immuno-Deficiency Trial in Worldwide (Intensified TB treatment (initial phase), WHO standard TB
Recruiting
- Tuberculosis
- +2 more
- Intensified TB treatment (initial phase)
- WHO standard TB treatment (initial phase)
-
Phnom Penh, Cambodia
- +5 more
May 3, 2022
Clinical Trial Trial in Moshi (Evaluation of high dose rifampicin in children)
Recruiting
- Clinical Trial
- Evaluation of high dose rifampicin in children
-
Moshi, Kilimanjaro, Tanzania
- +1 more
Sep 13, 2021
Plasmodium Falciparum Malaria, Malaria Diagnosis Trial in Ouagadougou (diagnostic test, drug, other)
Active, not recruiting
- Plasmodium Falciparum Malaria
- Malaria Diagnosis
- Additional screening using ultra sensitive RDTs
- +2 more
-
Ouagadougou, Kadiogo, Burkina FasoInstitut de Recherche en Sciences de la Santé/ Clinical Research
Dec 21, 2021
Tuberculosis, COVID-19, HIV Trial in Cape Town, Lusaka, Harare (CAD, Xpert)
Recruiting
- Tuberculosis
- +2 more
- CAD
- Xpert
-
Cape Town, Western Cape, South Africa
- +2 more
Mar 25, 2022
LAMP Assay for the Diagnosis of Visceral Leishmaniasis
Recruiting
- Visceral Leishmaniasis
-
Mekele, EthiopiaMekelle University College of Health Sciences
Aug 30, 2021
HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)
Active, not recruiting
- HIV-1-infection
- Vaccine
- Placebo
-
Kilifi, Kenya
- +3 more
Jun 21, 2022
Hotspots, Households and Hospitals: Enhanced Drug-resistant
Not yet recruiting
- Tuberculosis, Multidrug-Resistant
- (no location specified)
Aug 19, 2021
Trypanosoma Brucei Rhodesiense; Infection Trial in Rumphi, Lwala (Fexinidazole)
Recruiting
- Trypanosoma Brucei Rhodesiense; Infection
-
Rumphi, Malawi
- +1 more
Aug 27, 2021
HIV-1-infection Trial in Nairobi
Recruiting
- HIV-1-infection
-
Nairobi, KenyaKenya Medical Research Institute
Jul 19, 2021
Plasmodium Falciparum Malaria Trial in Burkina Faso, Congo, The Democratic Republic of the, Mali (artemether:lumefantrine (2.5
Recruiting
- Plasmodium Falciparum Malaria
- artemether:lumefantrine (2.5 mg:30 mg)
-
Nanoro, Burkina Faso
- +5 more
Nov 28, 2022
Sarcopenia Trial in Kingston 7 (High intensity exercise, Usual care home exercise)
Terminated
- Sarcopenia
- High intensity exercise
- Usual care home exercise
-
Kingston 7, KSA, JamaicaUWI Solutions for Developing Countries (SODECO)
Mar 17, 2021
Pharmacokinetics of Atazanavir in Special Populations
Active, not recruiting
- HIV/AIDS
- Tuberculosis
- Atazanavir 300mg/ Ritonavir 100 mg once daily
- Atazanavir 250 mg / ritonavir 80 mg
-
Cape Town, Western Cape, South Africa
- +3 more
Sep 22, 2021
SARS-CoV-2, BCG, Health Care Worker Trial in Praia (Questionaire)
Enrolling by invitation
- SARS-CoV-2
- +3 more
- Questionaire
-
Praia, Santiago, Cape VerdeUniversidade de Cabo Verde
Jul 7, 2021
Tuberculosis, Pulmonary Trial in South Africa, Tanzania (H56:IC31, Placebo)
Recruiting
- Tuberculosis, Pulmonary
- H56:IC31
- Placebo
-
Bellville, Cape Town, South Africa
- +5 more
Sep 27, 2021